Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dowsett

Showing results (191-200 of 304) with videos related to

Pageof 31
Sort By:
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
Clinical Endocrinology|February 1, 1985
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancerR Stuart-Harris, M Dowsett, A D'Souza, et al.
Breast Cancer Research and Treatment|December 25, 2003
Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancerL Assersohn, J Salter, T J Powles, et al.
Cancer Research|May 15, 1989
Intratumoral aromatase as a prognostic factor in human breast carcinomaM C Silva, M G Rowlands, M Dowsett, et al.
Lancet (London, England)|July 22, 1998
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialT Powles, R Eeles, S Ashley, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Control of aromatase in breast cancer cells and its importance for tumor growthM Dowsett, V Macaulay, J Gledhill, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patientsM Dowsett, A Mehta, N King, et al.
Cancer Research|March 1, 1990
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949AR C Stein, M Dowsett, J Davenport, et al.
British Journal of Cancer|April 26, 2012
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancerS Barton, L Zabaglo, R A'Hern, et al.
Journal of Enzyme Inhibition|January 1, 1992
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.
Pageof 31

Showing results (191-200 of 304) with videos related to

Sort By:
Pageof 31
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
Clinical Endocrinology|February 1, 1985
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancerR Stuart-Harris, M Dowsett, A D'Souza, et al.
Breast Cancer Research and Treatment|December 25, 2003
Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancerL Assersohn, J Salter, T J Powles, et al.
Cancer Research|May 15, 1989
Intratumoral aromatase as a prognostic factor in human breast carcinomaM C Silva, M G Rowlands, M Dowsett, et al.
Lancet (London, England)|July 22, 1998
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialT Powles, R Eeles, S Ashley, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
Control of aromatase in breast cancer cells and its importance for tumor growthM Dowsett, V Macaulay, J Gledhill, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patientsM Dowsett, A Mehta, N King, et al.
Cancer Research|March 1, 1990
Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949AR C Stein, M Dowsett, J Davenport, et al.
British Journal of Cancer|April 26, 2012
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancerS Barton, L Zabaglo, R A'Hern, et al.
Journal of Enzyme Inhibition|January 1, 1992
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.
Pageof 31